Jheng, H
Secondary outcome measurements included reduction in body weight from baseline by at least 5% or 10% by week 26, changes in waist circumference, total cholesterol, HDL, LDL, VLDL, and triglycerides, and levels of different glycemic variables including HbA1C, fasting plasma glucose, fasting insulin, insulin resistance, and the functioning of beta-cells
Long-Term Effects Studies suggest that GLP-1 medications are effective for sustaining weight loss when paired with ongoing lifestyle changes, emphasizing the importance of long-term commitment to healthy habits
Combining retatrutide with strength training and increased protein consumption might provide additional benefits in preserving muscle during weight loss
Both medications require gradual dose escalation and consistent weekly dosing to be effective and well-tolerated
Also, a mouse model for late-onset mitochondrial myopathy due to overexpression of mutated Twinkle protein, a nuclear-encoded replicative helicase of mtDNA, showed clear health improvements after 10 months of KD
